Nivolumab vs Trazodone

## Nivolumab vs Trazodone: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Trazodone**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Trazodone**: Serotonin antagonist and reuptake inhibitor (SARI).

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Trazodone — 5-9 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Trazodone — C19H22ClN5O.

**Molecular Weight**: Nivolumab — N/A; Trazodone — 371.8640 g/mol.

**Type**: Nivolumab — Antibody; Trazodone — Small molecule.